Myoepithelial expression of Fas and strong nuclear expression of FasL in epithelial cells: A marker for risk stratification of breast cancer.

dc.contributor.authorRanade, K J
dc.contributor.authorNerurkar, A V
dc.contributor.authorPhulpagar, M D
dc.contributor.authorShirsat, N V
dc.date.accessioned2013-01-21T09:20:13Z
dc.date.available2013-01-21T09:20:13Z
dc.date.issued2012-01
dc.description.abstractAim: The clinical significance of Fas and FasL in hormone-sensitive carcinomas has been reported. Our objective was to evaluate the expression of apoptosis-regulating genes Fas and FasL in Indian breast cancer and fibroadenoma patients in relation to hormone receptor status. Study Design: Retrospective. Materials and Methods: Paraffin-embedded tissue samples from 63 untreated female patients with invasive ductal carcinoma (IDC) and 32 female patients with fibroadenoma were studied. Expression of Fas and FasL was evaluated using immunohistochemical staining method. Statistical Analysis: Fisher's exact test and nonparametric correlation test (Spearman rank correlation test) were performed. Result: Fas was detected in 97% of the fibroadenomas and there was a slight decrease in levels of expression with histological grades of IDC. The expression of FasL was detected in 75% fibroadenomas and its expression increased in IDC. There was no correlation between Fas, FasL expression and hormone receptor status. Strong expression of Fas in myoepithelial cells was noted in 12 out of 32 fibroadenoma cases. Conclusion: Expression of Fas and FasL alone is unlikely to be important as a predictive factor as they express in both normal and malignant breast epithelium. But strong expression of Fas in myoepithelial cells along with strong nuclear expression of FasL in epithelial cells of fibroadenoma could be useful as an early predictive factor for onset of malignancy.en_US
dc.identifier.citationRanade K J, Nerurkar A V, Phulpagar M D, Shirsat N V. Myoepithelial expression of Fas and strong nuclear expression of FasL in epithelial cells: A marker for risk stratification of breast cancer. Indian Journal of Cancer. 2012 Jan-Mar; 49(1): 60-65.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/144553
dc.language.isoenen_US
dc.source.urihttps://www.indianjcancer.com/article.asp?issn=0019-509X;year=2012;volume=49;issue=1;spage=60;epage=65;aulast=Ranadeen_US
dc.subjectApoptosisen_US
dc.subjectfibroadenomaen_US
dc.subjectFasen_US
dc.subjectFasLen_US
dc.subjectinvasive ductal carcinomaen_US
dc.subject.meshAdult
dc.subject.meshApoptosis
dc.subject.meshApoptosis Regulatory Proteins --genetics
dc.subject.meshApoptosis Regulatory Proteins --metabolism
dc.subject.meshBreast Neoplasms --genetics
dc.subject.meshBreast Neoplasms --metabolism
dc.subject.meshBreast Neoplasms --pathology
dc.subject.meshEpithelium --metabolism
dc.subject.meshFas Ligand Protein --genetics
dc.subject.meshFas Ligand Protein --metabolism
dc.subject.meshFemale
dc.subject.meshFibroadenoma --genetics
dc.subject.meshFibroadenoma --metabolism
dc.subject.meshGene Expression Regulation, Neoplastic
dc.subject.meshHumans
dc.subject.meshMiddle Aged
dc.subject.meshMuscle Cells --metabolism
dc.subject.meshRetrospective Studies
dc.subject.meshRisk Factors
dc.titleMyoepithelial expression of Fas and strong nuclear expression of FasL in epithelial cells: A marker for risk stratification of breast cancer.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijc2012v49n1p60.pdf
Size:
1.24 MB
Format:
Adobe Portable Document Format
Description:
Journal article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: